HYDROLYSIS OF [R(R,R)]-2-(4-FLUOROPHENYL)-(3,6-DIHYDROXY-5-(1-METHYLETHYL)-3-PHENYL-4-[(PHENYLAMINO)CARBONYL]-1H-PYRROLE-1-HEPTANOIC ACID ESTERS WITH CALCIUM HYDROXIDE

HYDROLYSIS OF [R(R,R)]-2-(4-FLUOROPHENYL)-(3,6-DIHYDROXY-5-(1-METHYLETHYL)-3-PHENYL-4-[(PHENYLAMINO)CARBONYL]-1H-PYRROLE-1-HEPTANOIC ACID ESTERS WITH CALCIUM HYDROXIDE

The present invention provides a process for preparing atorvastatin hemi-calcium from an atorvastatin ester derivative with calcium hydroxide. The process is conveniently incorporated into a process for preparing atorvastatin hemi-calcium from an acetonide protected, ester protected beta,delta-dihyd...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: REVITAL LIFSHITZ-LIRON, RAMI LIDOR-HADAS, ETI ISHAI, VALERIE NIDDAM-HILDESHEIM
Format: Patent
Sprache:eng
Schlagworte:
APPARATUS THEREFOR
CHEMISTRY
GENERAL METHODS OF ORGANIC CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator REVITAL LIFSHITZ-LIRON
RAMI LIDOR-HADAS
ETI ISHAI
VALERIE NIDDAM-HILDESHEIM
description The present invention provides a process for preparing atorvastatin hemi-calcium from an atorvastatin ester derivative with calcium hydroxide. The process is conveniently incorporated into a process for preparing atorvastatin hemi-calcium from an acetonide protected, ester protected beta,delta-dihydroxy heptanoic acid precursor compound by a first acid hydrolysis step followed by base hydrolysis with calcium hydroxide. The latter process may be performed as a one-pot process.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_HRP20030454A2</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>HRP20030454A2</sourcerecordid><originalsourceid>FETCH-epo_espacenet_HRP20030454A23</originalsourceid><addsrcrecordid>eNqNjcuKwjAYhbuZhTi-Q5hVCh7oTfcxTUkgbcrflDGIiEhcDaOg7zSvOWJ9ADfnAt_hzJI_HWpyNgxmYK5hO-K0pHSPArxCY0dHrteqCzYFL5dr1OY52AaswHO0yutgn5KixISiwo5PUbSmc6kUtHGPtkeu0Qd6HCrk0Kr3onNGMiFNzdTgFQ3s23jNpLDSjC2bzkytPpOP8_HnFhcvnydfjfJSI14vh3i7Hk_xN94Pmvoiy8qsWlWiKN-C_gFcA0bE</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>HYDROLYSIS OF [R(R,R)]-2-(4-FLUOROPHENYL)-(3,6-DIHYDROXY-5-(1-METHYLETHYL)-3-PHENYL-4-[(PHENYLAMINO)CARBONYL]-1H-PYRROLE-1-HEPTANOIC ACID ESTERS WITH CALCIUM HYDROXIDE</title><source>esp@cenet</source><creator>REVITAL LIFSHITZ-LIRON ; RAMI LIDOR-HADAS ; ETI ISHAI ; VALERIE NIDDAM-HILDESHEIM</creator><creatorcontrib>REVITAL LIFSHITZ-LIRON ; RAMI LIDOR-HADAS ; ETI ISHAI ; VALERIE NIDDAM-HILDESHEIM</creatorcontrib><description>The present invention provides a process for preparing atorvastatin hemi-calcium from an atorvastatin ester derivative with calcium hydroxide. The process is conveniently incorporated into a process for preparing atorvastatin hemi-calcium from an acetonide protected, ester protected beta,delta-dihydroxy heptanoic acid precursor compound by a first acid hydrolysis step followed by base hydrolysis with calcium hydroxide. The latter process may be performed as a one-pot process.</description><edition>7</edition><language>eng</language><subject>APPARATUS THEREFOR ; CHEMISTRY ; GENERAL METHODS OF ORGANIC CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><creationdate>2005</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20051031&amp;DB=EPODOC&amp;CC=HR&amp;NR=P20030454A2$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20051031&amp;DB=EPODOC&amp;CC=HR&amp;NR=P20030454A2$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>REVITAL LIFSHITZ-LIRON</creatorcontrib><creatorcontrib>RAMI LIDOR-HADAS</creatorcontrib><creatorcontrib>ETI ISHAI</creatorcontrib><creatorcontrib>VALERIE NIDDAM-HILDESHEIM</creatorcontrib><title>HYDROLYSIS OF [R(R,R)]-2-(4-FLUOROPHENYL)-(3,6-DIHYDROXY-5-(1-METHYLETHYL)-3-PHENYL-4-[(PHENYLAMINO)CARBONYL]-1H-PYRROLE-1-HEPTANOIC ACID ESTERS WITH CALCIUM HYDROXIDE</title><description>The present invention provides a process for preparing atorvastatin hemi-calcium from an atorvastatin ester derivative with calcium hydroxide. The process is conveniently incorporated into a process for preparing atorvastatin hemi-calcium from an acetonide protected, ester protected beta,delta-dihydroxy heptanoic acid precursor compound by a first acid hydrolysis step followed by base hydrolysis with calcium hydroxide. The latter process may be performed as a one-pot process.</description><subject>APPARATUS THEREFOR</subject><subject>CHEMISTRY</subject><subject>GENERAL METHODS OF ORGANIC CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2005</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNjcuKwjAYhbuZhTi-Q5hVCh7oTfcxTUkgbcrflDGIiEhcDaOg7zSvOWJ9ADfnAt_hzJI_HWpyNgxmYK5hO-K0pHSPArxCY0dHrteqCzYFL5dr1OY52AaswHO0yutgn5KixISiwo5PUbSmc6kUtHGPtkeu0Qd6HCrk0Kr3onNGMiFNzdTgFQ3s23jNpLDSjC2bzkytPpOP8_HnFhcvnydfjfJSI14vh3i7Hk_xN94Pmvoiy8qsWlWiKN-C_gFcA0bE</recordid><startdate>20051031</startdate><enddate>20051031</enddate><creator>REVITAL LIFSHITZ-LIRON</creator><creator>RAMI LIDOR-HADAS</creator><creator>ETI ISHAI</creator><creator>VALERIE NIDDAM-HILDESHEIM</creator><scope>EVB</scope></search><sort><creationdate>20051031</creationdate><title>HYDROLYSIS OF [R(R,R)]-2-(4-FLUOROPHENYL)-(3,6-DIHYDROXY-5-(1-METHYLETHYL)-3-PHENYL-4-[(PHENYLAMINO)CARBONYL]-1H-PYRROLE-1-HEPTANOIC ACID ESTERS WITH CALCIUM HYDROXIDE</title><author>REVITAL LIFSHITZ-LIRON ; RAMI LIDOR-HADAS ; ETI ISHAI ; VALERIE NIDDAM-HILDESHEIM</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_HRP20030454A23</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2005</creationdate><topic>APPARATUS THEREFOR</topic><topic>CHEMISTRY</topic><topic>GENERAL METHODS OF ORGANIC CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><toplevel>online_resources</toplevel><creatorcontrib>REVITAL LIFSHITZ-LIRON</creatorcontrib><creatorcontrib>RAMI LIDOR-HADAS</creatorcontrib><creatorcontrib>ETI ISHAI</creatorcontrib><creatorcontrib>VALERIE NIDDAM-HILDESHEIM</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>REVITAL LIFSHITZ-LIRON</au><au>RAMI LIDOR-HADAS</au><au>ETI ISHAI</au><au>VALERIE NIDDAM-HILDESHEIM</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>HYDROLYSIS OF [R(R,R)]-2-(4-FLUOROPHENYL)-(3,6-DIHYDROXY-5-(1-METHYLETHYL)-3-PHENYL-4-[(PHENYLAMINO)CARBONYL]-1H-PYRROLE-1-HEPTANOIC ACID ESTERS WITH CALCIUM HYDROXIDE</title><date>2005-10-31</date><risdate>2005</risdate><abstract>The present invention provides a process for preparing atorvastatin hemi-calcium from an atorvastatin ester derivative with calcium hydroxide. The process is conveniently incorporated into a process for preparing atorvastatin hemi-calcium from an acetonide protected, ester protected beta,delta-dihydroxy heptanoic acid precursor compound by a first acid hydrolysis step followed by base hydrolysis with calcium hydroxide. The latter process may be performed as a one-pot process.</abstract><edition>7</edition><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_epo_espacenet_HRP20030454A2
source esp@cenet
subjects APPARATUS THEREFOR
CHEMISTRY
GENERAL METHODS OF ORGANIC CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
title HYDROLYSIS OF [R(R,R)]-2-(4-FLUOROPHENYL)-(3,6-DIHYDROXY-5-(1-METHYLETHYL)-3-PHENYL-4-[(PHENYLAMINO)CARBONYL]-1H-PYRROLE-1-HEPTANOIC ACID ESTERS WITH CALCIUM HYDROXIDE
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-03T18%3A35%3A52IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=REVITAL%20LIFSHITZ-LIRON&rft.date=2005-10-31&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EHRP20030454A2%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true